Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Gynecologic Oncology|December 9, 2008
Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumorsUrsula A Matulonis, Karen J Krag, Carolyn N Krasner, et al.
The Journal of Reproductive Medicine|January 2, 2015
Comparison of outcomes in patients with early-stage mucinous endometrial cancer and those with endometrioid endometrial cancer, with and without adjuvant therapySharon Owusu-Darko, J Alejandro Rauh-Hain, Neil S Horowitz, et al.
Gynecologic Oncology|March 22, 2003
Adequate staging for uterine cancer can be performed through Pfannenstiel incisionsNeil S Horowitz, Matthew A Powell, Charles W Drescher, et al.
Gynecologic Oncology|June 25, 2002
The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignanciesNeil S Horowitz, David E Cohn, Thomas J Herzog, et al.
Gynecologic Oncology|February 11, 2020
Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasiaIzildinha Maestá, Roni Nitecki, Cecilia Canedo Freitas Desmarais, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2015
Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasiaIzildinha Maestá, Neil S Horowitz, Donald P Goldstein, et al.
Gynecologic Oncology|May 28, 2013
Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasiaIzildinha Maestá, Whitfield B Growdon, Donald P Goldstein, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 11, 2025
Antibody-drug Conjugate Biomarker Expression in Gestational Trophoblastic Disease: Folate Receptor Alpha, Nectin-4, Trop-2, and Tissue FactorLawrence Hsu Lin, Kathleen T Hasselblatt, Carlos Parra-Herran, et al.
Gynecologic Oncology|November 3, 2017
Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experienceIzildinha Maestá, Roni Nitecki, Neil S Horowitz, et al.
The Journal of Reproductive Medicine|July 19, 2016
Maternal Near Miss According to World Health Organization Classification Among Women with a Hydatidiform Mole: Experience at the New England Trophoblastic Disease Center, 1994-2013Sue Yazaki Sun, Donald P Goldstein, Marilyn R Bernstein, et al.
Pageof 15